无条件隐性扩散模型记住了患者成像数据
Salman Ul Hassan Dar1,2,3,4, Marvin Seyfarth5,6,7, Isabelle Ayx8
1Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany. SalmanUlHassan.Dar@med.uni-heidelberg.de.
Nature biomedical engineering
|August 12, 2025
概括
生成性AI模型可以记住患者数据,冒着重新识别的风险. 隐性扩散模型显示高记忆能力,需要仔细训练和验证合成医疗数据隐私.
科学领域:
- 人工智能的人工智能
- 医疗成像医学成像
- 数据 隐私 数据 隐私 数据
背景情况:
- 生成型人工智能模型创建合成数据用于开放共享,但风险患者数据记忆和重新识别.
- 当模型复制,而不是生成新型样本时,就会发生患者数据的记忆.
研究的目的:
- 评估无条件潜伏扩散模型中的数据记忆.
- 评估生成模型对患者数据记忆的易感性.
主要方法:
- 在各种数据集上训练无条件潜伏扩散模型.
- 采用自我监督的复制检测方法来识别记住的患者数据.
- 在不同的生成模型 (扩散与自动编码器,GAN) 中比较记忆率.
主要成果:
- 在所有数据集中观察到高患者数据记忆率 (37.2%记忆,68.7%合成样本作为副本).
- 潜在扩散模型表现出比自动编码器和GAN更大的记忆能力,尽管合成质量优越.
- 训练策略如增强,更小的架构和更大的数据集减少了记忆;过度训练增加了它.
结论:
- 隐性扩散模型由于高数据记忆,造成了重大隐私风险.
- 在使用私人医疗成像数据的生成模型时,仔细的培训和验证至关重要.
- 确保合成数据的完整性对于在人工智能驱动的医疗保健中维护患者隐私至关重要.
相关概念视频
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Models of Health Promotion and Illness Prevention II
The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results from...
The agent-host-environment model states that disease results from...
Model Approaches for Pharmacokinetic Data: Compartment Models
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Censoring Survival Data
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...


